These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1945971)

  • 1. Intraperitoneal chemotherapy via the Groshong catheter in the patient with gynecologic cancer.
    Hrozenick SP; Ness EA
    Oncol Nurs Forum; 1991; 18(7):1245-6. PubMed ID: 1945971
    [No Abstract]   [Full Text] [Related]  

  • 2. Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients.
    Gleeson NC; Fiorica JV; Mark JE; Pinelli DM; Hoffman MS; Roberts WS; Cavanagh D
    Gynecol Oncol; 1993 Dec; 51(3):372-6. PubMed ID: 8112648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Groshong catheter as an intraperitoneal access device in the treatment of ovarian cancer patients.
    Naumann RW; Alvarez RD; Partridge EE; Kilgore LC; Austin JM
    Gynecol Oncol; 1993 Sep; 50(3):291-3. PubMed ID: 8406189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insertion of Groshong central venous catheters utilizing fluoroscopic techniques.
    Burnett AF; Lossef SV; Barth KH; Grendys EC; Johnson JC; Barter JF; Barnes WA
    Gynecol Oncol; 1994 Jan; 52(1):69-73. PubMed ID: 8307504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified technique for insertion of intraperitoneal port for chemotherapy.
    Liou WS; Teng NN; Chan JK
    J Surg Oncol; 2005 Jun; 90(4):247-8. PubMed ID: 15906367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experience of a totally implantable venous catheter for gynecologic cancer patients].
    Dozono H; Kamiwatari M; Ikeda S; Shinmura R; Miwa K; Nagata Y; Unoki Y; Arima N
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):2023-5. PubMed ID: 2592825
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraperitoneal therapy administered through a Groshong catheter.
    Waggoner SE; Johnson J; Barter J; Barnes W
    Gynecol Oncol; 1994 Jun; 53(3):320-5. PubMed ID: 8206405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of Groshong central venous catheters on a gynecologic oncology service.
    Holloway RW; Orr JW
    Gynecol Oncol; 1995 Feb; 56(2):211-7. PubMed ID: 7896188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients.
    Koonings PP; Given FT
    J Am Coll Surg; 1994 Feb; 178(2):164-6. PubMed ID: 8173727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy in the gynecologic oncology].
    Minerva Med; 1971 Apr; 62(28):1474-5. PubMed ID: 5567640
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experience of a subcutaneously implantable drug delivery catheter (PORT-A-CATH)].
    Kimura K; Koide A; Suga S; Shimoyama T; Okamoto E; Utsunomiya J; Okawa T; Taguchi T; Wakui A
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1150-5. PubMed ID: 3566308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use and nursing of intraperitoneal chemotherapy for ovarian cancer].
    Gao SY; Han JH; Li HY
    Zhonghua Hu Li Za Zhi; 1996 Apr; 31(4):211-2. PubMed ID: 8826214
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy monitoring for women with advanced malignant genital tumor].
    Zheng HJ
    Zhonghua Hu Li Za Zhi; 1997 May; 32(5):268-9. PubMed ID: 9304988
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nursing care of the patient with sexual organ cancer under continuous infusion therapy].
    Fujiwara J; Hajima N; Mori H; Kamoto R
    Kango Gijutsu; 1983 Apr; 29(6):821-7. PubMed ID: 6554378
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytoreductive surgery for gynecologic malignancies--new standards of care.
    Suh-Burgmann E; Powell CB
    Surg Oncol Clin N Am; 2007 Jul; 16(3):667-82, x-xi. PubMed ID: 17606200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
    Petru E; Benedicic Ch; Huell A
    Gynecol Oncol; 2006 Jul; 102(1):129; author reply 130. PubMed ID: 16600354
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pro and con a completely implantable catheter system].
    Thies H; Mlasowsky B
    Zentralbl Chir; 1987; 112(21):1367-76. PubMed ID: 3124368
    [No Abstract]   [Full Text] [Related]  

  • 18. Subcutaneous venous access for chemotherapy.
    Matsumoto T; Pavlides C; McDonald B; Brodsky I
    Pa Med; 1984 Nov; 87(11):56, 58, 61. PubMed ID: 6542645
    [No Abstract]   [Full Text] [Related]  

  • 19. Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer.
    Black D; Levine DA; Nicoll L; Chou JF; Iasonos A; Brown CL; Sonoda Y; Chi DS; Leitao MM; Abu-Rustum NR; Ferguson SE; Barakat RR
    Gynecol Oncol; 2008 Apr; 109(1):39-42. PubMed ID: 18234300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Theoretical and experimental bases for intraperitoneal chemotherapy in abdominal neoplastic processes].
    Marinov L
    Khirurgiia (Sofiia); 1986; 39(4):11-7. PubMed ID: 3784379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.